FR2944795B1 - Hydrolysats peptidiques activateurs du proteasome et compositions les contenant - Google Patents

Hydrolysats peptidiques activateurs du proteasome et compositions les contenant

Info

Publication number
FR2944795B1
FR2944795B1 FR0901980A FR0901980A FR2944795B1 FR 2944795 B1 FR2944795 B1 FR 2944795B1 FR 0901980 A FR0901980 A FR 0901980A FR 0901980 A FR0901980 A FR 0901980A FR 2944795 B1 FR2944795 B1 FR 2944795B1
Authority
FR
France
Prior art keywords
hydrolysats
proteasome
activators
peptide
compositions containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR0901980A
Other languages
English (en)
Other versions
FR2944795A1 (fr
Inventor
Farra Claude Dal
Nouha Domloge
Jean Marie Botto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ISP Investments LLC
Original Assignee
ISP Investments LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ISP Investments LLC filed Critical ISP Investments LLC
Priority to FR0901980A priority Critical patent/FR2944795B1/fr
Publication of FR2944795A1 publication Critical patent/FR2944795A1/fr
Application granted granted Critical
Publication of FR2944795B1 publication Critical patent/FR2944795B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0815Tripeptides with the first amino acid being basic
    • C07K5/0817Tripeptides with the first amino acid being basic the first amino acid being Arg
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K4/00Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
    • C07K4/06Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof from fungi
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K4/00Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
    • C07K4/10Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof from plants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1019Tetrapeptides with the first amino acid being basic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Botany (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)
FR0901980A 2009-04-23 2009-04-23 Hydrolysats peptidiques activateurs du proteasome et compositions les contenant Active FR2944795B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR0901980A FR2944795B1 (fr) 2009-04-23 2009-04-23 Hydrolysats peptidiques activateurs du proteasome et compositions les contenant

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0901980A FR2944795B1 (fr) 2009-04-23 2009-04-23 Hydrolysats peptidiques activateurs du proteasome et compositions les contenant

Publications (2)

Publication Number Publication Date
FR2944795A1 FR2944795A1 (fr) 2010-10-29
FR2944795B1 true FR2944795B1 (fr) 2013-08-02

Family

ID=41557682

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0901980A Active FR2944795B1 (fr) 2009-04-23 2009-04-23 Hydrolysats peptidiques activateurs du proteasome et compositions les contenant

Country Status (1)

Country Link
FR (1) FR2944795B1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2962038B1 (fr) * 2010-07-01 2013-01-18 Isp Investments Inc Utilisation d'un extrait peptidique de pois en tant qu'agent actif antioxydant dans une composition cosmetique
FR2987998B1 (fr) * 2012-03-19 2014-04-25 Isp Investments Inc Composition cosmetique comprenant un systeme activateur de la proteine trf2 a action synergique constitue d'une association d'un extrait peptidique de soja et de levure et ses utilisations

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2822701B1 (fr) * 2001-04-03 2005-03-18 Lvmh Rech Utilisation d'un extrait d'algue phaeodactylum comme agent cosmetique favorisant l'activite du proteasome des cellules de la peau et composition cosmetique le contenant
FR2904552B1 (fr) * 2006-08-03 2012-09-21 Soc Extraction Principes Actif Utilisation d'un extrait de levure en tant qu'agent actif pour augmenter la synthese de melanine dans les melanocytes
WO2008015343A2 (fr) * 2006-08-03 2008-02-07 Societe D'extraction Des Principes Actifs Sa (Vincience) Utilisation d'un extrait de levure en tant qu'agent actif pour augmenter la synthese de melanine dans les melanocytes
FR2915382B1 (fr) * 2007-04-27 2012-06-01 Vincience Utilisation d'un principe actif issu du mais (zea mays l) pour preparer une composition destinee a activer le cytochrome c
FR2915380B1 (fr) * 2007-04-27 2012-06-08 Vincience Utilisateur d'un principe actif issu du riz (oryza sativa l) pour preparer une composition destinee a activer le cytochrome c
FR2915378B1 (fr) * 2007-04-27 2009-08-21 Vincience Sa Utilisation d'un principe actif issu du soja (glycine max l.) pour preparer une composition destinee a proteger les mitochondries
FR2915381B1 (fr) * 2007-04-27 2012-06-08 Vincience Utilisation d'un principe actif issu du soja (glycine max l) pour preparer une composition destinee a activer le cytochrome c
FR2915379B1 (fr) * 2007-04-27 2012-07-13 Vincience Utilisation d'un principe actif issu du riz (oryza sativa l) pour preparer une composition destinee a proteger les mitochondries
FR2915384B1 (fr) * 2007-04-27 2010-01-15 Vincience Utilisation d'un principe actif issu du soja (glycine maxl.) pour preparer une composition destinee a activer l'energie cellulaire et a proteger la peau des dommages oxydatifs.
FR2915383B1 (fr) * 2007-04-27 2010-01-15 Vincience Utilisation d'un principe actif issu du riz (oryza sativa l.) pour preparer une composition destinee a activer l'energie cellulaire et a proteger la peau des dommages oxydatifs.

Also Published As

Publication number Publication date
FR2944795A1 (fr) 2010-10-29

Similar Documents

Publication Publication Date Title
FR2944797B1 (fr) Hydrolysats peptidiques activateurs du proteasome et compositions les contenant
LTC2618831I2 (lt) Makrocikliniai iš prolino gauti HCV serino proteazės inhibitoriai
HK1250313A1 (zh) 穩定的藥物組合物和使用所述組合物的方法
SMT201700036B (it) Composti e composizioni come inibitori di protein chinasi
SMT201600291B (it) Inibitori di proteasi hcv
HK1203929A1 (en) Inhibitors of hcv ns5a hcv ns5a
HK1208686A1 (en) Aromatic-cationic peptides and uses of same
EP2575866A4 (fr) Inhibiteurs de ns5a du vhc
EP2575475A4 (fr) Inhibiteurs de ns5a de vhc
SI2193142T1 (sl) Sestavek in postopek za uporabo proislet peptidov in analogov le-teh
EP2398474A4 (fr) Inhibiteurs du ns5a du vhc
ZA201104911B (en) Inhibitors of hcv ns5a
EP2442829A4 (fr) Compositions de peptides viraux structurés et procédés d'utilisation
EP2364161A4 (fr) Compositions contenant des satiogènes et leurs procédés d'utilisation
EP2566880A4 (fr) Peptides aromatiques-cationiques et leurs applications
IL208403A0 (en) Compositions and use of epas1 inhibitors
EP2421901A4 (fr) Composition contenant le complexe hc ha et procédés d'utilisation de celle-ci
EP2364159A4 (fr) Inhibiteurs macrocycliques deutériés de la protéase virale ns3
EP2453904A4 (fr) Compositions de films minces et procedes de synthese et d utilisation correspondants
FR2944798B1 (fr) Hydrolysats peptidiques eclaircissants activateurs du proteasome et compositions les contenant
BR112013010836A2 (pt) inibidores específicos de ns3 protease de hcv
FR2944016B1 (fr) Nouveaux peptides anti-age activateurs du proteasome et compositions les contenant
FR2944018B1 (fr) Nouveaux peptides anti-age activateurs du proteasome et compositions les contenant
FR2944795B1 (fr) Hydrolysats peptidiques activateurs du proteasome et compositions les contenant
FR2946347B1 (fr) Agents anti-age et compositions les contenant

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 11

PLFP Fee payment

Year of fee payment: 12

PLFP Fee payment

Year of fee payment: 13

PLFP Fee payment

Year of fee payment: 14

PLFP Fee payment

Year of fee payment: 15

PLFP Fee payment

Year of fee payment: 16